The scientific journal Nature has published a list of technologies it expects to come to the forefront in 2023, and genomics features heavily.
CRISPR gets a mention, with the hypothesis that the ever-growing CRISPR-based toolbox could eventually 'allow us to edit any base that we want.'
In vitro embryo models are also listed, with advances in the development of embryo models with extra embryonic precursor cells, as well as progress made with induced pluripotent stem cells, both explored.
Single-molecule protein sequencing and single-cell metabolomics are also forecast to build on single-cell transcriptomics and genomic sequencing techniques, to give an even deeper understanding of the cell.
